4.7 Article

Antidepressant-like effect of Ganoderma lucidum spore polysaccharide-peptide mediated by upregulation of prefrontal cortex brain-derived neurotrophic factor

期刊

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
卷 105, 期 23, 页码 8675-8688

出版社

SPRINGER
DOI: 10.1007/s00253-021-11634-y

关键词

Ganoderma lucidum spores; Polysaccharide-peptide; Antidepressant; Monoamine neurotransmitters; Corticosterone; Brain-derived neurotrophic factor

资金

  1. Collaborative Innovation Center of Beijing Academy of Agricultural and Forestry Sciences [KJCX201915]
  2. Beijing Academy of Agriculture and Forestry Science [KJCX20200208]

向作者/读者索取更多资源

A 28-kDa polysaccharide-peptide with antidepressant-like activities was isolated from the spores of Ganoderma lucidum, showing similarities with proteins from other mushroom species. This compound enhanced cell viability, reduced stress hormone levels, and influenced brain neurotransmitters and proteins, suggesting a potential BDNF-dependent mechanism.
A 28-kDa polysaccharide-peptide (PGL) with antidepressant-like activities was isolated from spores of the mushroom Ganoderma lucidum. It was unadsorbed on DEAE-cellulose. Its internal amino acid sequences manifested pronounced similarity with proteins from the mushrooms Lentinula edodes and Agaricus bisporus. The monosaccharides present in 28-kDa PGL comprised predominantly of glucose (over 90%) and much fewer galactose, mannose residues, and other residues. PGL manifested antidepressant-like activities as follows. It enhanced viability and DNA content in corticosterone-injured PC12 cells(a cell line derived from a pheochromocytoma of the rat adrenal medulla with an embryonic origin from the neural crest containing a mixture of neuroblastic cells and eosinophilic cells) and reduced LDH release. A single acute PGL treatment shortened the duration of immobility of mice in both tail suspension and forced swimming tests. PGL treatment enhanced sucrose preference and shortened the duration of immobility in mice exposed to chronic unpredictable mild stress (CUMS). Chronic PGL treatment reversed the decline in mouse brain serotonin and norepinephrine levels but did not affect dopamine levels. PGL decreased serum corticosterone levels and increased BDNF mRNA and protein levels and increased synapsin I and PSD95 levels in the prefrontal cortex. This effect was completely blocked by pretreatment with the BDNF antagonist K252a, indicating that PGL increased synaptic proteins in a BDNF-dependent manner.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据